Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3K Hold
11,000
﹤0.01% 500
2025
Q4
$6.18K Sell
11,000
-3,350
-23% -$3.5K ﹤0.01% 491
2025
Q3
$20.8K Hold
14,350
﹤0.01% 487
2025
Q2
$26.1K Hold
14,350
﹤0.01% 504
2025
Q1
$31.7K Hold
14,350
﹤0.01% 473
2024
Q4
$59.4K Hold
14,350
﹤0.01% 477
2024
Q3
$24.4K Hold
14,350
﹤0.01% 474
2024
Q2
$23.8K Hold
14,350
﹤0.01% 463
2024
Q1
$157K Hold
14,350
﹤0.01% 467
2023
Q4
$52.7K Buy
+14,350
New +$36.2K ﹤0.01% 464

Other funds holding NOTV

Glenview Trust's NOTV Position: Q1 2026 in Review

Glenview Trust held its Inotiv (NOTV) position steady in Q1 2026 at 11,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Glenview Trust first reported a position in NOTV in Q4 2023 and has held it in 10 quarters since. The position peaked at $157K in Q1 2024. 50 funds tracked by Wall St. Rank hold NOTV as of Q1 2026.

  • Glenview Trust held 11,000 shares of Inotiv worth $3K as of Q1 2026.
  • Glenview Trust left its Inotiv share count unchanged in Q1 2026.
  • Inotiv made up ﹤0.01% of Glenview Trust's portfolio in Q1 2026, its #500 holding.
  • Glenview Trust first reported a position in Inotiv in Q4 2023 and has held it in 10 quarters since.
  • Glenview Trust's Inotiv position peaked at $157K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Inotiv as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.